BGLAP and Parkinson disease: In PD rat models, CSF OCN levels were significantly reduced, while OCN treatment mitigated the loss of tyrosine hydroxylase, a key enzyme involved in DA synthesis within the nigrostriatal pathway (Guo et al., 2018).